THERE IS MUCH EVIDENCE to support the idea that human tumours are able to provoke humoral and cellular immune responses. Supportive evidence includes the histological appearance of draining lymph nodes, in which follicular hyperplasia of B lymphocytes and enlargement of T-lymphocyte areas are frequently observed (Kaufmann et al., 1977) . These lymphocytes might have been stimulated by the antigens of tumour cells, but the precise antigenic specificities of these lymphocytes remain to be elucidated. In this respect, characterization of human monoclonal antibodies produced by immortalizing lymphocytes of regional lymph nodes would answer the question concerning B lymphocytes. A few hybrid cell lines producing human monoclonal antibodies specific to tumours have been developed by fusing lymphocytes of lymph nodes draining human tumours with murine myeloma cells (Schlom et al., 1980; Sikora & Wright, 1981) . There is an alternative method for producing human monoclonal antibodies. Epstein-Barr virus (EBV) transforms human B lymphocytes into lymphoblastoid cells secreting immunoglobulins. This property of EBV has been applied by several investigators to the production of specific antibodies in vitro (Steinitz et al., 1977; Luzzanti et al., 1977 ).
An antibody against a human tumourassociated oncofoetal antigen (OFA-I) was also produced by transforming peripheral blood lymphocytes of melanoma patients (Irie et al., 1981) . In this report, we employed this method to immortalize the Aecepted 12 August 1982 lymphocytes of lymph nodes draining human lung cancers and analysed the specificities of antibodies produced using immunohistochemical methods.
An EBV-producing marmoset cell line, B-95-8, was used as the source of EBV (Miller & Lipman, 1973 Hilar lymph nodes were obtained at surgery from one case each of moderately differentiated adenocarcinoma (Case 1) and large-cell carcinoma (Case 2) of the lung. The tumour of Case 1, which was resected from a 69-year-old male, was 5 x 3-5 cm in size and hilar lymph nodes showed metastases. The tumour of Case 2, which was resected from a 55-year-old male, was 2-5 x 2 cm in size and had also metastasized to the hilar lymph nodes. Non-tumorous regions of these lymph nodes showed follicular hyperplasia histologically. Single-cell suspensions were prepared from such regions and were resuspended in the culture medium at a cell concentration of 1 x 107/ml, to which 2 volumes of the virus stock were added. The mixture was shaken for 2 h at 37°C, and diluted with the culture medium to obtain a cell concentration of 1 x 105/ml. Then, 0-1 ml of the diluted cell suspension was distributed to each well of 96-well tissue culture plates. The plates were kept in a humidified incubator at 37°C with 7% CO2 and half the medium was exchanged every 3-4 days.
During 4 weeks of culture, a small number of colonies of lymphoblastoid cells developed in each well. The cells in each well were then transferred to each well of 24-well tissue culture plates, and 1-5 ml of the culture medium was added. After an additional 2 weeks of culture, culture supernatants were individually screened for the presence of antibody against human lung cancer xenografts, which consisted of one each of adenocarcinoma (Lu-66), squamous-cell carcinoma (Lu-61), small-cell carcinoma (Lu-i), and largecell carcinoma (Lu-116) (Shimosato et al., 1979) . The reason why we selected the xenografted tumour as the target tissue of screening is due to the difficulty of staining human tissues with human antibodies. If one stains human tissues with human antibodies using anti-human immunoglobulins as the second antibody in the immunohistochemical method, endogenous human immunoglobulins in the human tissues elicit some background staining. In this respect xenografted tumours, which are devoid of human immunoglobulins, are more suitable as the target tissue.
Sections of formalin-fixed tissues containing both xenografted tumours and various organs of host nude mice were immunohistochemically stained with the culture supernatants. A 4-step immuno- peroxidase technique using peroxidaseantiperoxidase complex as the final step was applied (Sternberger, 1979 with rabbit anti-human immunoglobulins, diluted 1:100, swine anti-rabbit immunoglobulins, diluted 1: 20, and rabbit peroxidase-antiperoxidase complex, diluted 1:50, for 30 min. Then the sections were developed for 5-10 min in 0-05M Tris HCl, pH 7-6, containing 0.02% 3,3'-diaminobenzidine and 0.005% H202. Finally, the sections were counterstained with haematoxylin. Four of 24 wells in Case 1 and 7/24 wells in Case 2 contained antibodies which clearly reacted with the human lung cancer xenografts, but these antibodies also reacted with some normal cells of mice. These antibodies were divided into 4 types depending upon their staining pattern (Table I, Figs 1, 3) . In addition, a few wells contained antibodies which reacted with erythrocytes or leucocytes of mice, but not with human lung cancer xenografts. (Fig. 4) . However, they also reacted with some normal cells in autologous human lungs (Table II, Fig. 2 ). Bronchial and alveolar epithelium (cytoplasm, diffuse) In this study, we demonstrated clearly that human antibodies reactive with human lung cancers could be produced in vitro by EBV transformation of lymphocytes in draining lymph nodes of lung cancers. However, the antibodies obtained were not tumour-specific, because they reacted with some normal cells of human lungs. In addition they were heterophilic, because they reacted with some normal cells of mice. From these findings, it is concluded that in the draining lymph nodes some B lymphocytes are present which react with both neoplastic cells and autologous and heterologous normal cells. It has been considered that lymphocyte proliferation in the regional lymph nodes may be induced by tumour-specific antigens (Kaufmann et al., 1977) . However, our data so far support the possibility that some B lymphocytes in the regional lymph nodes were stimulated not by the tumourspecific antigens but by the antigens commonly present in both neoplastic and normal cells.
